You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 20, 2024

Litigation Details for INDIVIOR INC. v. ALVOGEN PINE BROOK, INC. (D.N.J. 2017)


✉ Email this page to a colleague

« Back to Dashboard


INDIVIOR INC. v. ALVOGEN PINE BROOK, INC. (D.N.J. 2017)

Docket ⤷  Try a Trial Date Filed 2017-09-14
Court District Court, D. New Jersey Date Terminated
Cause 35:271 Patent Infringement Assigned To Kevin McNulty
Jury Demand None Referred To
Parties ALVOGEN PINE BROOK LLC; ALVOGEN PINE BROOK, INC.; AQUESTIVE THERAPEUTICS, INC.; INDIVIOR INC.; INDIVIOR UK LIMITED; MATTHEW J. BECKER
Patents 10,357,571; 10,519,211; 6,344,215; 7,579,326; 7,659,254; 7,659,256; 7,772,243; 7,772,267; 7,931,212; 8,349,571; 8,475,832; 8,603,514; 9,084,824; 9,296,687; 9,382,297; 9,579,288; 9,579,305; 9,687,454; 9,752,099; 9,849,099; 9,849,118; 9,931,305; 9,931,336; 9,931,357; 9,931,382
Attorneys AMANDA LYN GENOVESE; ARNOLD B. CALMANN; CHARLES MICHAEL LIZZA; DAVID LEIGH MOSES; JAMIE L. LUCIA; KATHERINE ANN ESCANLAR; KATHERINE HARIHAR; PHILIP SCOTT MAY; WILLIAM C. BATON
Firms O'Melveny and Myers LLP; One CityCenter; Saul Ewing Arnstein & Lehr LLP; Steptoe & Johnson LLP; Troutman Sanders LLP
Link to Docket External link to docket
Small Molecule Drugs cited in INDIVIOR INC. v. ALVOGEN PINE BROOK, INC.

Details for INDIVIOR INC. v. ALVOGEN PINE BROOK, INC. (D.N.J. 2017)

Date Filed Document No. Description Snippet Link To Document
2019-11-05 215 film is also covered by Patent No. 8,603,514 (“the ‘514 Patent”). The ‘514 Patent shares the same specification…7111 at DE 250-1). “514 Patent” = United States Patent No. 8,603,514, P1. Ex. C (Dkt. No. 7106 at…and Alvogen. The patents-in-suit are Patent Nos. 9,931,305 (“the ‘305 Patent”), issued to Aquestive…Aquestive. The patent for that film, the ‘514 Patent, was issued on December 10, 2013.2 (‘514 Patent at [45j,…films” in the ‘514 Patent. Id. at 1027. In reviewing the ‘305 Patent and the ‘514 Patent, the Federal Circuit External link to document
2019-11-19 217 obtained U.S. Patent Nos. 9,931,305 and 9,687,454 (the “’305 patent” and the “’454 patent,” respectively…events of the above motions. Following a related patent infringement litigation in the District of Delaware…respectively) and subsequently asserted patent infringement claims against DRL and Alvogen in various cases in…Indivior was unlikely to succeed on the merits of its patent infringement claim. Indivior Inc. v. Dr. Reddy’…judgment and forfeiture of various trademarks, patents, assets and receivables. III. DISCUSSION External link to document
2020-05-05 288 Order on Motion to Bifurcate obtained U.S. Patent Nos. 9,931,305 and 9,687,454 (the “’305 patent” and the “’454 patent,” respectively…adjudication. Depomed Inc. v. Purdue Pharma L.P., 13-cv-571 (JAP), 2013 WL 6190380, at *9 (D.N.J. Nov. 26, …for purposes of this opinion. (Dkt No. 7111 at 357; Dkt. No. 7106 at 272.) On January 23, 2020, the …consolidated patent infringement lawsuits brought by Indivior concerning various Suboxone patents. Before… ‘454 patent infringement claim, Defendants’ antitrust counterclaims related to the ‘305 patent will External link to document
2020-08-24 320 Opinion U.S. Patent No. 8,475,832 (“the ’832 Patent”). This ’514 Patent and the ’832 Patent are not directly at…DE 250-1). “’832 Patent” = United States Patent No. 8,475,832. …the ’305 Patent and Claim 62 of the ’514 Patent. 5 The ’832 Patent and the ’454 Patent have the…18217 The patents-in-suit are Patent Nos. 9,931,305 (“the ’305 Patent”), issued to Aquestive…film is also covered by Patent No. 8,603,514 (“the ’514 Patent”). The ’514 Patent shares the same specification External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.